Industry Verticals »

All Categories

Insights »

About TMR »

Testosterone Replacement Therapy Market

Testosterone Replacement Therapy Market (Product - Creams/Gels, Patches, Injections, Gums/Buccal Adhesives, Implants; Active Ingredient - Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global testosterone replacement therapy market for the historical period 2017–2018 and forecast period 2019–2027, increasing incidence of testosterone deficiency, growing awareness among people regarding testosterone replacement therapy, and a significant pipeline of medications, are projected to drive the global market for testosterone replacement therapy during the forecast period
  • According to the report, the global testosterone replacement therapy market was valued at US$ 1,613.7 Mn in 2018 and is anticipated to expand at a CAGR of 4.4% from 2019 to 2027

global testosterone replacement therapy market

Rising incidence of testosterone deficiency: Key Drivers

  • Testosterone deficiency, also known as hypogonadism, is characterized by diminished functioning of the male gonads that reduces testosterone secretion. This occurs mainly due to hypothalamic-pituitary axis dysfunction and/or testicular failure.
  • Testosterone deficiency is one of the common health problems among men aged between 40 years and 79 years. The incidence of low testosterone levels in men aged over 60 years is estimated to be around 20% of the male population, and in the population aged over 70 years, around 30%. The global prevalence of testosterone deficiency ranges from over 10% to 40% of the population.
  • However, only around 9% of patients with testosterone deficiency are being treated in the U.S. This is due to factors such as the perceived risk of prostate cancer associated with current treatment therapy and lack of screening/tests for low testosterone. Therefore, an increase in the incidence rate of testosterone deficiency is expected to drive the testosterone replacement therapy products market in the near future.

Rise in Geriatric Population with High Risk of Testosterone Deficiency Boost Market Growth

  • The world population is aging rapidly, especially in some of the developed economies such as the U.S., most of Western Europe, and Japan. Developed economies present high rates of aging. This is attributed to improved healthcare infrastructure, policies, and advancement in healthcare facilities in these countries. Moreover, access to various diagnostic and treatment services has improved in the recent past, especially in developed economies. This in turn has increased the life expectancy of the population.
  • According to World Health Organization (WHO) estimates, the global geriatric population is likely to reach around 2 billion (22% of the global population) by 2050 as compared to 524 million in 2010. The geriatric population would rise at the fastest rate in developed countries such as the U.K., Germany, the U.S., and Japan. However, Brazil, China, Thailand, and South Korea are also expected to have a large geriatric population base in the shortest span of time in the near future.
  • Testosterone levels decrease naturally as age increases beyond 30 years. However, in some cases, the significant decreases can lead to health problems. The world population is rapidly aging. Therefore, with the increasing population of aged individuals, the testosterone-deficient men population would also grow, which in turn would increase the demand for testosterone replacement therapy in the global market. Hence, an increase in the geriatric population is expected to fuel the growth of the testosterone replacement therapy market globally

Patent Expiry of Key Drugs and Entry of Generics Hamper Market

  • The testosterone replacement therapy market is expected to experience a patent cliff during the forecast period. The expiration of key drug patents would affect the revenues of large pharmaceutical companies from TRT products. In addition, the generic versions of these drugs would further reduce the global market revenues as these would be priced much lower than their counterparts (branded drugs) that dominated the global market earlier.
  • This factor is expected to have a profound effect on the overall testosterone replacement therapy products market, causing a drastic dip in market revenues. Moreover, approved ANDAs for most of these molecules will lead to intense generic competition.
  • Therefore, patent expirations are likely to significantly impact and restrain the testosterone replacement therapy industry in the near future.

Global Testosterone replacement therapy Market: Competitive Landscape

  • This report profiles major players in the global testosterone replacement therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global market for testosterone replacement therapy is highly consolidated, with the top five players accounting for over 60% of the market.
  • Leading players operating in the global testosterone replacement therapy business are
    • AbbVie, Inc.
    • Allergan plc
    • Bayer AG
    • Endo Pharmaceuticals, Inc.
    • Eli Lilly Company
    • Kyowa Kirin International plc
    • Mylan N.V.
    • Novartis AG
    • Pfizer, Inc.
    • Clarus Therapeutics,
    • Ferring Holding SA,

Global Testosterone replacement therapy Industry: Key Developments

Key players in the global testosterone replacement therapy market are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market. A few product launches in the global market is:

  • In April 2019, the U.S. FDA approved a generic version of testosterone gel 1.62% as replacement therapy for men with hypogonadism.
  • In March 2019, the U.S. FDA approved Jatenzo, an oral testosterone capsule, manufactured by Clarus Therapeutics for the treatment of certain forms of hypogonadism.

The report on the global market for testosterone replacement therapy discussed individual strategies, followed by company profiles of manufacturers of testosterone replacement therapy. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global testosterone replacement therapy market.

Frequently Asked Questions

How big was the global testosterone replacement therapy market in 2018?

The global TRT market was valued at US$ 1,613.7 Mn in 2018

What is the total market worth of testosterone replacement therapy?

The testosterone replacement therapy industry is anticipated to expand at a CAGR of 4.4% from 2019 to 2027

What is the anticipated CAGR of the global market for testosterone replacement therapy in the forecast period?

The testosterone replacement therapy market is to reach a value of USD 2,296.2 Mn by the end of 2027

What are the key driving factors for the growth of the testosterone replacement therapy business?

Testosterone replacement therapy market is driven by rise in geriatric population with high risk of testosterone deficiency

Who are the key players in the testosterone replacement therapy industry?

Key players in the global market for testosterone replacement therapy include AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly Company

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Testosterone Replacement Therapy Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Testosterone Replacement Therapy Market Analysis and Forecast, 2017-2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Pricing Analysis: Testosterone Replacement Therapy Market, by Product, (US$) 2018

    5.2. Pipeline Analysis: Testosterone Replacement Therapy

    5.3. TRT Technology Development Timeline

6. Global Testosterone Replacement Therapy Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Testosterone Replacement Therapy Market Value Forecast, by Type, 2017-2027

        6.2.1. Creams/Gels

        6.2.2. Patches

        6.2.3. Injections

        6.2.4. Gums/Buccal Adhesives

        6.2.5. Implants

        6.2.6. Oral

    6.3. Global Testosterone Replacement Therapy Market Attractiveness, by Type

7. Global Testosterone Replacement Therapy Market Analysis and Forecast, by Active Ingredient Type

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Testosterone Replacement Therapy Market Value Forecast, by Active Ingredient Type, 2017-2027

        7.2.1. Testosterone

        7.2.2. Methyl Testosterone

        7.2.3. Testosterone Undecanoate

        7.2.4. Testosterone Enanthate

        7.2.5. Testosterone Cypionate

    7.3. Global Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type

8. Global Testosterone Replacement Therapy Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Testosterone Replacement Therapy Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. North America Testosterone Replacement Therapy Market Attractiveness, by Region

9. North America Testosterone Replacement Therapy Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        9.2.1. Creams/Gels

        9.2.2. Patches

        9.2.3. Injections

        9.2.4. Gums/Buccal Adhesives

        9.2.5. Implants

        9.2.6. Oral

    9.3. North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

        9.3.1. Testosterone

        9.3.2. Methyl Testosterone

        9.3.3. Testosterone Undecanoate

        9.3.4. Testosterone Enanthate

        9.3.5. Testosterone Cypionate

    9.4. North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country, 2017-2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Testosterone Replacement Therapy Market Attractiveness Analysis

        9.5.1. By Product Type

        9.5.2. By Active Ingredient Type

        9.5.3. By Country

10. Europe Testosterone Replacement Therapy Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Type, 2017-2027

        10.2.1. Creams/Gels

        10.2.2. Patches

        10.2.3. Injections

        10.2.4. Gums/Buccal Adhesives

        10.2.5. Implants

        10.2.6. Oral

    10.3. Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

        10.3.1. Testosterone

        10.3.2. Methyl Testosterone

        10.3.3. Testosterone Undecanoate

        10.3.4. Testosterone Enanthate

        10.3.5. Testosterone Cypionate

    10.4. Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Europe Testosterone Replacement Therapy Market Attractiveness Analysis

        10.5.1. By Product Type

        10.5.2. By Active Ingredient Type

        10.5.3. By Country/Sub-region

11. Asia Pacific Testosterone Replacement Therapy Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        11.2.1. Creams/Gels

        11.2.2. Patches

        11.2.3. Injections

        11.2.4. Gums/Buccal Adhesives

        11.2.5. Implants

        11.2.6. Oral

    11.3. Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

        11.3.1. Testosterone

        11.3.2. Methyl Testosterone

        11.3.3. Testosterone Undecanoate

        11.3.4. Testosterone Enanthate

        11.3.5. Testosterone Cypionate

    11.4. Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Asia Pacific Testosterone Replacement Therapy Market Attractiveness Analysis

        11.5.1. By Type

        11.5.2. By Active Ingredient Type

        11.5.3. By Country/Sub-region

12. Latin America Testosterone Replacement Therapy Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        12.2.1. Creams/Gels

        12.2.2. Patches

        12.2.3. Injections

        12.2.4. Gums/Buccal Adhesives

        12.2.5. Implants

        12.2.6. Oral

    12.3. Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

        12.3.1. Testosterone

        12.3.2. Methyl Testosterone

        12.3.3. Testosterone Undecanoate

        12.3.4. Testosterone Enanthate

        12.3.5. Testosterone Cypionate

    12.4. Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America Latin America

    12.5. Latin America Testosterone Replacement Therapy Market Attractiveness Analysis

        12.5.1. By Product Type

        12.5.2. By Active Ingredient Type

        12.5.3. By Country/Sub-region

13. Middle East & Africa Testosterone Replacement Therapy Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        13.2.1. Creams/Gels

        13.2.2. Patches

        13.2.3. Injections

        13.2.4. Gums/Buccal Adhesives

        13.2.5. Implants

        13.2.6. Oral

    13.3. Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

        13.3.1. Testosterone

        13.3.2. Methyl Testosterone

        13.3.3. Testosterone Undecanoate

        13.3.4. Testosterone Enanthate

        13.3.5. Testosterone Cypionate

    13.4. Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa Testosterone Replacement Therapy Market Attractiveness Analysis

        13.5.1. By Product Type

        13.5.2. By Active Ingredient Type

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by Tier and Size of companies)

    14.2. Market Share / Position Analysis, by Company, 2018

    14.3. Competitive Business Strategies

    14.4. Company Profiles

        14.4.1. AbbVie, Inc.

            14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.1.2. Growth Strategies

            14.4.1.3. SWOT Analysis

        14.4.2. Allergan plc

            14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.2.2. Growth Strategies

            14.4.2.3. SWOT Analysis

        14.4.3. Bayer AG

            14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.3.2. Growth Strategies

            14.4.3.3. SWOT Analysis

        14.4.4. Endo Pharmaceuticals, Inc.

            14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.4.2. Growth Strategies

            14.4.4.3. SWOT Analysis

        14.4.5. Eli Lilly and Company

            14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.5.2. Growth Strategies

            14.4.5.3. SWOT Analysis

        14.4.6. Kyowa Kirin International plc

            14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.6.2. Growth Strategies

            14.4.6.3. SWOT Analysis

        14.4.7. Mylan N.V.

            14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.7.2. Growth Strategies

            14.4.7.3. SWOT Analysis

        14.4.8. Novartis AG

            14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.8.2. Growth Strategies

            14.4.8.3. SWOT Analysis

        14.4.9. Pfizer, Inc.

            14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.9.2. Growth Strategies

            14.4.9.3. SWOT Analysis

        14.4.10. Clarus Therapeutics

            14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.10.2. Growth Strategies

            14.4.10.3. SWOT Analysis

        14.4.11. Ferring Holding SA

            14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.11.2. Growth Strategies

            14.4.11.3. SWOT Analysis

List of Tables

Table 1: Global Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

Table 2: Global Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

Table 3: Global Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Region, 2017-2027

Table 4: North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 5: North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

Table 6: North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

Table 7: Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 8: Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

Table 9: Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

Table 10: Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 11: Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

Table 12: Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

Table 13: Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 14: Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

Table 15: Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

Table 16: Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 17: Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

Table 18: Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

List of Figures

Figure 1: Global Testosterone Replacement Therapy Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 2: Global Testosterone Replacement Therapy Market Value (US$ Mn) and Forecast, 2019-2027

Figure 3: Global Testosterone Replacement Therapy Market Value Share (%), by Product Type, 2018

Figure 4: Global Testosterone Replacement Therapy Market Value Share (%), by Active Ingredient Type, 2018

Figure 5: Global Testosterone Replacement Therapy Market Value Share (%), by Region, 2018

Figure 6: Global Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 7: Global Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

Figure 8: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Creams/Gels, 2017-2027

Figure 9: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Patches, 2017-2027

Figure 10: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Injections, 2017-2027

Figure 11: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gums/Buccal Adhesives, 2017-2027

Figure 12: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Implants, 2017-2027

Figure 13: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017-2027

Figure 14: Global Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

Figure 15: Global Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

Figure 16: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Testosterone, 2017-2027

Figure 17: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Methyl Testosterone, 2017-2027

Figure 18: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Testosterone Undecanoate, 2017-2027

Figure 19: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Testosterone Enanthate, 2017-2027

Figure 20: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Testosterone Cypionate, 2017-2027

Figure 21: Global Testosterone Replacement Therapy Market Value Share, by Region, 2018 and 2027

Figure 22: Global Testosterone Replacement Therapy Market Attractiveness, by Region, 2019-2027

Figure 23: North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 24: North America Testosterone Replacement Therapy Market Value Share Analysis, by Country, 2018 and 2027

Figure 25: North America Testosterone Replacement Therapy Market Attractiveness, by Country, 2019-2027

Figure 26: North America Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 27: North America Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

Figure 28: North America Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

Figure 29: North America Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

Figure 30: Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 31: Europe Testosterone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 32: Europe Testosterone Replacement Therapy Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 33: Europe Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 34: Europe Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

Figure 35: Europe Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

Figure 36: Europe Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

Figure 37: Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 38: Asia Pacific Testosterone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 39: Asia Pacific Testosterone Replacement Therapy Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 40: Asia Pacific Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 41: Asia Pacific Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

Figure 42: Asia Pacific Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

Figure 43: Asia Pacific Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

Figure 44: Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 45: Latin America Testosterone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 46: Latin America Testosterone Replacement Therapy Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 47: Latin America Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 48: Latin America Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

Figure 49: Latin America Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

Figure 50: Latin America Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

Figure 51: Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 52: Middle East & Africa Testosterone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 53: Middle East & Africa Testosterone Replacement Therapy Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 54: Middle East & Africa Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 55: Middle East & Africa Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

Figure 56: Middle East & Africa Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

Figure 57: Middle East & Africa Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Testosterone Replacement Therapy Market

Schedule a Call